| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT07570173 A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia… |
date change Primary completion pushed: 2029-02-10 -> 2033-10-18 |
| 2026-06-06 | NCT07570173 A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia… |
date change Completion pushed: 2029-10-02 -> 2033-10-18 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT07570173 | A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia… | B-cell Acute Lymphoblastic Leukemia | Recruiting |
| Phase 2 | |||
| NCT06470971 | Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT05684692 | Screening Trial for Pain Relief in Schwannomatosis (STARFISH) | Schwannomatosis | Recruiting |
| NCT06679829 | A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an… | Multiple Myeloma | Recruiting |
| Phase 1 | |||
| NCT06990711 | A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection… | Antibody Mediated Rejection of Lung Transplant | Recruiting |